The Downside Of Declassifying Cannabis As A Schedule 1 Drug

The Fresh Toast
By Terry HaciendaMar 10, 2022, 1:07 pm216 pts
The Downside Of Declassifying Cannabis As A Schedule 1 Drug It is essential that rescheduling is done in a way that boosts existing state markets rather than undermining them. The post The Downside Of Declassifying Cannabis As A Schedule 1 Drug appeared first on The Fresh Toast.

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Collective Project Launches Portfolio of Hemp-Derived THC Beverages in 25 States 67

Last Week in Weed: July 1- July 8, 2025 67

Auxly Cannabis reaches ‘turning point’ with closing of 2 transactions 67

Hemp vs. THC: Inside the Industry’s Identity Crisis 66

Oregon Police Improperly Used Aerial Camera To Bust Marijuana Grow, State Appeals Court Says 65

Texas: Dallas Officials Halt Implementation of Voter-Approved Marijuana Depenalization Ordinance 64

Nature’s Heritage Brings Old-School Genetics to the Modern Market 63

4 Pitfalls to Avoid When Seeking a Cannabis Trademark (and Tips to Avoid Them) 63

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.